RxDoctor Payments Data

Dayna Dobson, PA

Physician Assistant · Bend, ORNPI 1023669645

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.3%), food and beverage and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 74.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,480, 6.5 times the $229 reported in 2022. Among physician assistant clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,951in general payments, 2019–2025

Across 16 payments — averaging $121.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Atricure, Inc.$142
  • Amgen$125
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$112
  • Medtronic$47
  • Edwards Lifesciences$45
  • plus $35 from 2 others

What the payments were for

  • Travel & lodging$1,05954%
  • Food & beverage$87745%
  • Education$151%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,951 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon →

Medicare billing

Part B allowed, 2024
$34,011
Medicare patients
309
Services billed
401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$71,587
EntrestoSacubitril/Valsartan26$29,080
Repatha SureclickEvolocumab36$28,734
JardianceEmpagliflozin27$26,256
XareltoRivaroxaban11$17,727
Metoprolol Succinate193$3,137
Rosuvastatin Calcium68$1,380
Ezetimibe21$1,130
Atorvastatin Calcium81$1,103
Midodrine Hcl11$991
Amiodarone Hcl35$942
ClopidogrelClopidogrel Bisulfate55$657
Flecainide Acetate21$650
Potassium Chloride42$637
Losartan Potassium69$632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$71,58769 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Bend

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →